MedTrace Logo

ROTEM® Obstetric Hemorrhage Pilot Study

NCT04409015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-09-21

No results posted yet for this study

Summary

This is a prospective observational study among women at high-risk of postpartum hemorrhage, in their third trimester who are admitted to Labor \&Delivery in spontaneous labor, for induction of labor, or for scheduled cesarean section.

Conditions

  • High Risk Postpartum Hemorrhage (PPH)

Interventions

DEVICE

ROTEM - rotation thromboelastometry testing

The ROTEM® is a simple blood test that provides information about specific components involved in blood clotting and stopping hemorrhage.

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-27
Primary Completion
2021-01-30
Completion
2022-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04409015 on ClinicalTrials.gov